Invivyd
Manufacturing · Connecticut, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
209 Church St, New Haven, Connecticut, 0...Phone Number
(781) 819-0080Website
www.invivyd.comRevenue
$53.4 MillionStock Symbol
IVVDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Invivyd
Invivyd, Inc. is a biopharmaceutical company focused on developing innovative antibody-based therapies to protect against evolving viral threats. It uses a proprietary discovery and engineering platform to create potent monoclonal antibodies for prevention and treatment of infectious diseases. The company emphasizes cutting-edge research, viral surveillance, and adaptive solutions to address emerging health challenges globally.Explore more
Invivyd Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Invivyd your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Invivyd launches new products
Earning: See what the market has to say on Invivyd recently announced quarterly report
Invivyd, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Invivyd has new funding data
Check out if Invivyd is spiking on competitors!
Click to see if Invivyd had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Invivyd
Website visits: Recent activity has been detected on your website
Check if Invivyd has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Invivyd
Find more new buyers
Compare Similar Companies to Invivyd
Compare insights from companies similar to Invivyd, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Invivyd is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Invivyd is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Invivyd.
Invivyd financials insights
Gather financial insights about Invivyd, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$50M
Series B
$80M
2021
Series C
$336M
Share Placement
$309.4M
Invivyd Tech Stack
A closer look at the technologies used by Invivyd
See more technologies
Most Recent Scoops
Open Position
Person-Based
Spending/Investment, Clinical Operations
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Invivyd News & Media
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW HAVEN, Conn., June 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on June 1, 2026, Invivyd granted 17 newly hired non-executive employees options to purchase an aggregate of 513,500 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
NEW HAVEN, Conn., June 01, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced the completion of enrollment in the DECLARATION trial evaluating VYD2311, an investigational monoclonal antibody candidate for the prevention of symptomatic COVID-19. DECLARATION is the company’s Biologics License Application (BLA)-enabling, Phase 3 randomized, placebo-controlled clinical trial to evaluate VYD2311 efficacy and safety in prevention of symptomatic COVID in a broad population of particiInvivyd to Participate in Upcoming Investor Events
NEW HAVEN, Conn., May 27, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will participate in upcoming investor events in June:Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now
Invivyd Inc. (NASDAQ:IVVD) is one of the best NASDAQ stocks under $5 to buy right now. On May 14, Invivyd reported earnings for Q1 2026, highlighted by $13.7 million in PEMGARDA net product revenue, which marks a 22% growth compared to Q1 2025. The company ended the quarter with $184.2 million in cash and cash […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Invivyd
Sign Up For FreeTo access detailed company insights
Invivyd, Inc. is a biopharmaceutical company focused on developing innovative antibody-based therapies to protect against evolving viral threats. It uses a proprietary discovery and engineering platform to create potent monoclonal antibodies for prevention and treatment of infectious diseases. The company emphasizes cutting-edge research, viral sur... Read More
